7 results on '"Vietor, Ann Christin"'
Search Results
2. Genetic diversity of enteric viruses responsible of gastroenteritis in urban and rural Burkina Faso.
- Author
-
Badjo, Ange Oho Roseline, Niendorf, Sandra, Jacobsen, Sonja, Zongo, Arsène, Mas Marques, Andreas, Vietor, Ann Christin, Kabore, Nongodo Firmin, Poda, Armel, Some, Satouro Arsène, Ouattara, Aminata, Ouangraoua, Soumeya, Schubert, Grit, Eckmanns, Tim, Leendertz, Fabian H., Belarbi, Essia, and Ouedraogo, Abdoul-Salam
- Subjects
ENTEROVIRUSES ,GASTROENTERITIS ,VIRAL gastroenteritis ,GENETIC variation ,CAMPYLOBACTER jejuni ,VIRUS diversity ,NEUROCYSTICERCOSIS - Abstract
Background: Viral gastrointestinal infections remain a major public health concern in developing countries. In Burkina Faso, there are very limited updated data on the circulating viruses and their genetic diversity. Objectives: This study investigates the detection rates and characteristics of rotavirus A (RVA), norovirus (NoV), sapovirus (SaV) and human astrovirus (HAstV) in patients of all ages with acute gastrointestinal infection in urban and rural areas. Study design & Methods: From 2018 to 2021, stool samples from 1,295 patients with acute gastroenteritis were collected and screened for RVA, NoV, SaV and HAstV. Genotyping and phylogenetic analyses were performed on a subset of samples. Results: At least one virus was detected in 34.1% of samples. NoV and SaV were predominant with detection rates of respectively 10.5 and 8.8%. We identified rare genotypes of NoV GII, RVA and HAstV, recombinant HAstV strains and a potential zoonotic RVA transmission event. Conclusions: We give an up-to-date epidemiological picture of enteric viruses in Burkina Faso, showing a decrease in prevalence but a high diversity of circulating strains. However, viral gastroenteritis remains a public health burden, particularly in pediatric settings. Our data advocate for the implementation of routine viral surveillance and updated management algorithms for diarrheal disease. Author summary: Diseases of the gastrointestinal tract can be caused by a variety of pathogens, such as bacteria, viruses, fungi or parasites. Viruses play a particularly important role, especially in low-income countries, where viral gastroenteritis leads to high morbidity and mortality, particularly among children and the elderly. As part of the African Network for Improved Diagnostics, Epidemiology and Management of Common Infectious Agents (ANDEMIA), patients of all ages from four African countries with symptoms of acute gastroenteritis were tested for the most common viral, bacterial and parasitic pathogens. Samples from Burkina Faso that tested positive for noroviruses, rotaviruses, sapoviruses or astroviruses were further genotyped and characterized in the present study. In this study we described for the first time the detection of rare rotavirus and astrovirus strains circulating in Burkinabe patients. The knowledge about the circulating virus variants is essential to develop suitable vaccines and adequate pharmaceuticals. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Multicountry study of SARS-CoV-2 and associated risk factors among healthcare workers in Côte d'Ivoire, Burkina Faso and South Africa
- Author
-
Kribi, Sarah, primary, Touré, Fidèle, additional, Mendes, Adriano, additional, Sanou, Soufiane, additional, Some, Arsène, additional, Aminou, Abdoul M, additional, Belarbi, Essia, additional, Griessel, Rosemary, additional, Hema, Arsène, additional, Kabore, Firmin, additional, Pitzinger, Paul, additional, Strydom, Amy, additional, Vietor, Ann Christin, additional, Traoré, Korotimi, additional, Zongo, Arsène, additional, Anoh, Etilé A, additional, Grossegesse, Marica, additional, Hofmann, Natalie, additional, Ouangraoua, Soumeya, additional, Poda, Armel, additional, Kagone, Thérèse, additional, Schubert, Grit, additional, Eckmanns, Tim, additional, Venter, Marietjie, additional, Leendertz, Fabian, additional, Akoua-Koffi, Chantal, additional, and Tomczyk, Sara, additional
- Published
- 2022
- Full Text
- View/download PDF
4. Multicountry study of SARS-CoV-2 and associated risk factors among healthcare workers in Côte d'Ivoire, Burkina Faso and South Africa.
- Author
-
Kribi, Sarah, Touré, Fidèle, Mendes, Adriano, Sanou, Soufiane, Some, Arsène, Aminou, Abdoul M, Belarbi, Essia, Griessel, Rosemary, Hema, Arsène, Kabore, Firmin, Pitzinger, Paul, Strydom, Amy, Vietor, Ann Christin, Traoré, Korotimi, Zongo, Arsène, Anoh, Etilé A, Grossegesse, Marica, Hofmann, Natalie, Ouangraoua, Soumeya, and Poda, Armel
- Subjects
SARS-CoV-2 ,MEDICAL personnel - Abstract
Background Reports on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread across Africa have varied, including among healthcare workers (HCWs). This study assessed the comparative SARS-CoV-2 burden and associated risk factors among HCWs in three African countries. Methods A multicentre study was conducted at regional healthcare facilities in Côte d'Ivoire (CIV), Burkina Faso (BF) and South Africa (SA) from February to May 2021. HCWs provided blood samples for SARS-CoV-2 serology and nasopharyngeal/oropharyngeal swabs for testing of acute infection by polymerase chain reaction and completed a questionnaire. Factors associated with seropositivity were assessed with logistic regression. Results Among 719 HCWs, SARS-CoV-2 seroprevalence was 34.6% (95% confidence interval 31.2 to 38.2), ranging from 19.2% in CIV to 45.7% in BF. A total of 20 of 523 (3.8%) were positive for acute SARS-CoV-2 infection. Female HCWs had higher odds of SARS-CoV-2 seropositivity compared with males, and nursing staff, allied health professionals, non-caregiver personnel and administration had higher odds compared with physicians. HCWs also reported infection prevention and control (IPC) gaps, including 38.7% and 29% having access to respirators and IPC training, respectively, in the last year. Conclusions This study was a unique comparative HCW SARS-CoV-2 investigation in Africa. Seroprevalence estimates varied, highlighting distinctive population/facility-level factors affecting COVID-19 burden and the importance of established IPC programmes to protect HCWs and patients. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
5. Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance:A global survey
- Author
-
Tomczyk, Sara, Taylor, Angelina, Brown, Allison, de Kraker, Marlieke E. A., El-Saed, Aiman, Alshamrani, Majid, Hendriksen, Rene S., Jacob, Megan, Löfmark, Sonja, Perovic, Olga, Shetty, Nandini, Sievert, Dawn, Smith, Rachel, Stelling, John, Thakur, Siddhartha, Vietor, Ann Christin, Eckmanns, Tim, Tomczyk, Sara, Taylor, Angelina, Brown, Allison, de Kraker, Marlieke E. A., El-Saed, Aiman, Alshamrani, Majid, Hendriksen, Rene S., Jacob, Megan, Löfmark, Sonja, Perovic, Olga, Shetty, Nandini, Sievert, Dawn, Smith, Rachel, Stelling, John, Thakur, Siddhartha, Vietor, Ann Christin, and Eckmanns, Tim
- Abstract
Objectives: The COVID-19 pandemic has had a substantial impact on health systems. The WHO Antimicrobial Resistance (AMR) Surveillance and Quality Assessment Collaborating Centres Network conducted a survey to assess the effects of COVID-19 on AMR surveillance, prevention and control. Methods: From October to December 2020, WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) national focal points completed a questionnaire, including Likert scales and open-ended questions. Data were descriptively analysed, income/regional differences were assessed and free-text questions were thematically analysed. Results: Seventy-three countries across income levels participated. During the COVID-19 pandemic, 67% reported limited ability to work with AMR partnerships; decreases in funding were frequently reported by low- and middle-income countries (LMICs; P < 0.01). Reduced availability of nursing, medical and public health staff for AMR was reported by 71%, 69% and 64%, respectively, whereas 67% reported stable cleaning staff availability. The majority (58%) reported reduced reagents/consumables, particularly LMICs (P < 0.01). Decreased numbers of cultures, elective procedures, chronically ill admissions and outpatients and increased ICU admissions reported could bias AMR data. Reported overall infection prevention and control (IPC) improvement could decrease AMR rates, whereas increases in selected inappropriate IPC practices and antimicrobial prescribing could increase rates. Most did not yet have complete data on changing AMR rates due to COVID-19. Conclusions: This was the first survey to explore the global impact of COVID-19 on AMR among GLASS countries. Responses highlight important actions to help ensure that AMR remains a global health priority, including engaging with GLASS to facilitate reliable AMR surveillance data, seizing the opportunity to develop more sustainable IPC p
- Published
- 2021
6. Impact of the COVID-19 Pandemic on Antimicrobial Resistance (AMR) Surveillance, Prevention and Control: A Global Survey
- Author
-
Tomczyk, Sara, primary, Taylor, Angelina, additional, Brown, Allison, additional, Kraker, Marlieke de, additional, Eckmanns, Tim, additional, El-Saed, Aiman, additional, Alshamrani, Majid, additional, Hendriksen, Rene, additional, Jacob, Megan, additional, Löfmark, Sonja, additional, Perovic, Olga, additional, Shetty, Nandini, additional, Sievert, Dawn, additional, Smith, Rachel, additional, Stelling, John, additional, Thakur, Siddhartha, additional, Tornimbene, Barbara, additional, Vietor, Ann Christin, additional, and Eremin, Sergey, additional
- Published
- 2021
- Full Text
- View/download PDF
7. Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey.
- Author
-
Tomczyk, Sara, Taylor, Angelina, Brown, Allison, Kraker, Marlieke E A de, El-Saed, Aiman, Alshamrani, Majid, Hendriksen, Rene S, Jacob, Megan, Löfmark, Sonja, Perovic, Olga, Shetty, Nandini, Sievert, Dawn, Smith, Rachel, Stelling, John, Thakur, Siddhartha, Vietor, Ann Christin, Eckmanns, Tim, Network, the WHO AMR Surveillance and Quality Assessment Collaborating Centres, and de Kraker, Marlieke E A
- Subjects
COVID-19 pandemic ,MEDICAL personnel ,PUBLIC health surveillance ,INFECTION prevention ,COVID-19 ,ANTIMICROBIAL stewardship ,DRUG resistance in microorganisms - Abstract
Objectives: The COVID-19 pandemic has had a substantial impact on health systems. The WHO Antimicrobial Resistance (AMR) Surveillance and Quality Assessment Collaborating Centres Network conducted a survey to assess the effects of COVID-19 on AMR surveillance, prevention and control.Methods: From October to December 2020, WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) national focal points completed a questionnaire, including Likert scales and open-ended questions. Data were descriptively analysed, income/regional differences were assessed and free-text questions were thematically analysed.Results: Seventy-three countries across income levels participated. During the COVID-19 pandemic, 67% reported limited ability to work with AMR partnerships; decreases in funding were frequently reported by low- and middle-income countries (LMICs; P < 0.01). Reduced availability of nursing, medical and public health staff for AMR was reported by 71%, 69% and 64%, respectively, whereas 67% reported stable cleaning staff availability. The majority (58%) reported reduced reagents/consumables, particularly LMICs (P < 0.01). Decreased numbers of cultures, elective procedures, chronically ill admissions and outpatients and increased ICU admissions reported could bias AMR data. Reported overall infection prevention and control (IPC) improvement could decrease AMR rates, whereas increases in selected inappropriate IPC practices and antimicrobial prescribing could increase rates. Most did not yet have complete data on changing AMR rates due to COVID-19.Conclusions: This was the first survey to explore the global impact of COVID-19 on AMR among GLASS countries. Responses highlight important actions to help ensure that AMR remains a global health priority, including engaging with GLASS to facilitate reliable AMR surveillance data, seizing the opportunity to develop more sustainable IPC programmes, promoting integrated antibiotic stewardship guidance, leveraging increased laboratory capabilities and other system-strengthening efforts. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.